Importantly, the RFS prediction signature constructed on MICA, ULBP3, and ULBP5 could predict HCC recurrence in patients after hepatectomy and might provide a benefit in the management of postoperative patients as a valuable prediction tool. This evidence concerns the gene ULBP3 and hepatocellular carcinoma.